Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
WuXi Biologics Reports Remarkable 2022 Annual Results 2023-03-22 20:09
Jacobio announces clinical collaboration to evaluate CD73 monoclonal antibody JAB-BX102 in combination with KEYTRUDA® (pembrolizumab) for patients with cancer 2023-03-22 12:36
280Bio Provides Update on the KRAS Inhibitor TEB-17231 at the 2023 AACR Annual Meeting 2023-03-21 20:00
Kintor Pharma's KX-826 and GT20029 for Treatment of Androgenetic Alopecia (AGA) and Acne Presented at AAD 2023 2023-03-21 15:22
Hovione and Ripple Enter Strategic Partnership to Expand Epidel® Platform into Non-Ophthalmic Space 2023-03-20 21:00
CNEY Wins a Large Activated Carbon Order 2023-03-20 20:30
I-Mab to Report Full Year 2022 Financial Results and Provide Corporate Update on March 31, 2023 2023-03-20 20:00
Hanmi Pharmaceutical's Combination Drug for Dyslipidemia Treatment, 'Rosuzet': Confirmed Non-inferiority Efficacy and Safety Compared to Monotherapy in 'The Lancet' & 'European Heart Journal' 2023-03-17 21:00
Samsung Biologics announces construction of Plant 5 to commence Bio Campus II capacity expansion 2023-03-17 19:25
Nav1.7 Selective Inhibitor OLP-1002 Shows Strong Efficacy and Long Therapeutic Duration according to Interim Findings from a Phase 2a Study in OA Patients 2023-03-16 21:00
FDA Approves Expanded Indication for Telix's Illuccix® to Include Patient Selection for PSMA-Directed Radioligand Therapy 2023-03-16 20:28
Akeso Reported 2022 Annual Results 2023-03-16 08:26
Bridge Biotherapeutics to Present Updated Preclinical Data of BBT-207 at the AACR 2023 Annual Meeting 2023-03-15 21:00
HanAll Biopharma Opens Applications for the 2023 Pharmaceutical Industry Fellowship Program 2023-03-15 19:00
Nippon Express (Belgium) Joins Pharma.Aero 2023-03-15 14:00
Jacobio Pharma to Present Data of Three Preclinical Studies at the 2023 AACR Annual Meeting 2023-03-15 10:45
Ascentage Pharma to Present Latest Results from Three Preclinical Studies at 2023 American Association for Cancer Research Annual Meeting 2023-03-15 07:59
Mabwell Launched First in human Clinical Trial of Its Iron Homeostasis Regulating Macromolecular Drug 9MW3011 2023-03-14 23:42
Simcere Zaiming Announces Clinical Collaboration to Evaluate SIM0235, a TNFR2 Monoclonal Antibody, in Combination with KEYTRUDA® (pembrolizumab) in a Phase 1 Trial in Advanced Solid Tumors and Cutaneous T-cell Lymphoma 2023-03-14 20:00
Patient Enrollment Completed for Phase III Clinical Trial of Akeso's Cadonilimab in Treatment of Gastric Cancer 2023-03-14 17:01
1 36 37 38 39 40 146